Compare · EW vs OFLX
EW vs OFLX
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Omega Flex Inc. (OFLX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while OFLX operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 196.6x OFLX ($258.3M).
- EW has hit the wire 5 times in the past 4 weeks while OFLX has been quiet.
- EW has more recent analyst coverage (25 ratings vs 0 for OFLX).
- Company
- Edwards Lifesciences Corporation
- Omega Flex Inc.
- Price
- $86.61-1.66%
- $25.73-1.23%
- Market cap
- $50.78B
- $258.3M
- 1M return
- -1.84%
- -
- 1Y return
- +16.04%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 0
- Recent ratings
- 25
- 0
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Omega Flex Inc.
Omega Flex, Inc., together with its subsidiaries, manufactures and sells flexible metal hoses and accessories in the United States and internationally. It offers flexible gas piping for use in residential and commercial buildings, as well as its fittings; and corrugated medical tubing for use in hospitals, ambulatory care centers, dental, physician and veterinary clinics, laboratories, and other facilities. The company sells its products under the TracPipe, CounterStrike, AutoSnap, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac brand names. It serves various markets, including construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. The company sells its products through independent sales representatives, distributors, original equipment manufacturers, and direct sales, as well as through its website. The company was formerly known as Tofle America, Inc. and changed its name to Omega Flex, Inc. in 1996. Omega Flex, Inc. was incorporated in 1975 and is based in Exton, Pennsylvania.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest OFLX
- Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2026
- Omega Flex Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- President Moran Edwin B. bought $20,090 worth of shares (790 units at $25.43), increasing direct ownership by 79% to 1,790 units (SEC Form 4)
- Vice President - CFO Unger Matthew Francis bought $25,420 worth of shares (1,000 units at $25.42) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Omega Flex Inc.
- SEC Form 10-Q filed by Omega Flex Inc.
- Omega Flex, Inc. Announces Second Quarter 2026 Earnings and CE Mark Approval for MediTrac Corrugated Medical Tubing
- Omega Flex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omega Flex Re-Engineers Flexible Gas Piping Fittings for Superior Installation Experience
- SEC Form 11-K filed by Omega Flex Inc.